We are aware of the major software outage impacting systems around the world. BMC is fully operational and open to all patients.


Jean-Antoine Ribeil, MD, PHD, is a hematologist specializing in red blood cell disorders at Boston Medical Center (BMC), where he is the Clinical Director of the Center of Excellence in Sickle Cell Disease. Dr Ribeil is also an associate professor of Hematology & Oncology at Boston University Chobanian & Avedisian School of Medicine. He received his medical degree from Aix-Marseille in France and completed a doctorate in Cell and Molecular Biology from the University of Paris. Prior to moving to Boston in 2017, Dr. Ribeil served as the Medical Director of the Department of Biotherapy at Necker University in Paris, where he founded and directed a sickle cell referral center. Dr. Ribeil is an internationally recognized hematologist and a highly innovative leader in the treatment of sickle cell anemia. He is committed to developing clinical research, most notably in gene therapy for hemoglobinopathies.
  • Departments

  • Specialties

    Hemoglobinopathies, red blood cell disorders, sickle cell anemia

  • Languages

  • Pronouns

  • Administrative Title

    Clinical Director, Center of Excellence in Sickle Cell Disease; Associate Professor of Medicine, Boston University Chobanian and Avedisian School of Medicine

  • Residency

    Limoges University School of Medicine (France)
  • Fellowship

    Fellowship at University of Paris and Research Fellowship in Hematopoiesis and Immunology, Centre National de la Recherche Scientifique (CNRS)
  • Education

    Universite Aix Marseille II, 1995
  • Board Certifications

    Medicine, Hematology